Pancreatic ductal adenocarcinoma (PDAC) is a very serious type of cancer. It's hard to find early because there aren't many symptoms, and it's often diagnosed late. This study looks at a new, non-invasive way to detect PDAC by checking for microRNAs in the blood. MicroRNAs are tiny molecules that help control genes and can show signs of cancer. This method could be better than current tests, which are often invasive and expensive.

• **Eligibility:** Adults 18+ at high risk for PDAC can join.
• **Procedure:** No medicines; only lab tests on existing blood samples.
• **No direct treatment or devices:** Only blood sample analysis is involved.

To participate, you must be 18 or older and at high risk for PDAC. You need to have previously given blood samples and agreed to their use in research. If you've had pancreatic surgery or other cancers, you cannot join. The study involves lab work on your blood samples, with no direct impact on your current treatment. This non-invasive method aims to improve early cancer detection and monitoring.